Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00030352
DRKS00030352
Recruiting
Not Applicable

Validation of the falling stick test as screening test device for prodromal neurodegenerative diseases - FALL-DEG

Hans Berger Klinik für Neurologie, Universitätsklinikum Jena0 sites111 target enrollmentOctober 12, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG47.8F06.7Other sleep disordersMild cognitive disorder

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G47.8
Sponsor
Hans Berger Klinik für Neurologie, Universitätsklinikum Jena
Enrollment
111
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 12, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Hans Berger Klinik für Neurologie, Universitätsklinikum Jena

Eligibility Criteria

Inclusion Criteria

  • •Group 1: Patients of any gender with idiopathic REM sleep behavior disorder (prodromal Parkinson's disease) without parkinsonoid movement deficits, Age \>\= 18 years
  • •Group 2: Patients of any gender with amnestic Mild Cognitive Impairment (prodromal Alzheimer's disease), Age \>\= 18 years
  • •Group 3: Healthy control participants of any gender, adapted for age and gender, Age \>\= 18 years

Exclusion Criteria

  • •presence of a disease which could potentially impair the motor function or responsiveness, including the following:
  • •\- neurological diseases:
  • •o history of stroke
  • •o history of cerebral haemorrhage
  • •o multiple sclerosis
  • •o history of meningitis or encephalitis
  • •o chronic headache or migraine (duration \> 3 months, minimum of 15 days per month)
  • •o brain tumour
  • •o pronounced polyneuropathy with impairment of the upper extremities
  • •o neurodegenerative disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Validity of the Fingertip-to-floor test
DRKS00003075Philipps-Universität Marburg, Fachbereich Medizin, Studiengang Physiotherapie Master55
Not yet recruiting
Not Applicable
Development of a diagnostic method for pancreatic cancer by esophagogastroduodenoscopy using a synthetic human secretin preparation and a special catheterPersons at high risk of pancreatic cancerFamily history of pancreatic cancerC535836
JPRN-jRCTs051230169Shinich Yachida300
Recruiting
Not Applicable
sefulness of a screening test for pancreatic cancer by detection of gene mutations in duodenal juice collected using secretin and a specially-made catheter following gastrointestinal endoscopy in high-risk individuals
JPRN-jRCTs051200116Yachida Shinichi120
Completed
Not Applicable
Survey tool for Screening of anemia in women before pregnancyHealth Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium
CTRI/2022/12/048408Eunice Kennedy Shriver National Institute of Child Health and Human Development503
Not yet recruiting
Not Applicable
Evaluation study of a rapid test and treatments for Chagas disease in Bahia, BrazilMass ScreeningDrug therapyC01.920.625
RBR-5zfkxdyCentro de Pesquisas Gonçalo Moniz